Global DTC (Direct to Consumer) DNA Test Kits Market Size

DTC (direct to consumer) DNA Test Kits Market Analysis

The DTC (Direct to Consumer) DNA test kits market is expected to register a CAGR of 15.70% over the forecast period (2022-2027).

The outbreak of the pandemic imposed a positive impact on the DTC (Direct to Consumer) DNA test kits market. Biopharmaceutical innovators are at the forefront of the human response to the COVID-19 pandemic. A significant number of major biotech firms are in a race to investigate the Sars-Cov-2 genome and prepare rapid testing for the same. As compared to the speed of response to SARS/MERs, etc. biotech entities are investigating in SARs-Cov-2 at an unprecedented rate, and a considerable amount of funds are being utilized for R&D activities. With multiple candidates in the trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a cure is developed for COVID-19. Genetic testing helps to identify variations that affect the response to COVID-19 and discover new therapies that could reduce harm, save lives, and even prevent future outbreaks. Thus, the demand for genetic testing has experienced sudden spikes due to the pandemic. In addition, the advantages of DTC DNA testing have positively impacted the market during COVID-19. Some of the major advantages include increasing access to testing at home that reduces the risk of exposure to the virus for consumers and medical personnel, and thereby reducing the risk of spreading infection.

However, disruption in the supply chain during COVID-19 and delay in delivery of essential products required for manufacturing DTC DNA kits imposed an adverse effect on the DTC (Direct to Consumer) DNA test kits market. Some major issues faced by the market during a pandemic include trucking bottlenecks and port checkpoints slowing down their deliveries including critical supplies, export bans imposed in many countries with only a few manufacturing units being functional, and lack of healthcare workers to transport and produce products. Therefore, such a restraining factor imposed an adverse impact on the market initially, however, in later times the positive developments helped the market to gain positive momentum, thereby propelling the market growth.

Increasing demand for paternity testing across the globe especially in the European countries is anticipated to propel the market growth over the forecast period. For instance, in February 2022, AlphaBiolabs received UKAS accreditation for prenatal paternity testing in the United Kingdom for the first time. In addition, as per the journal published by the AlphaBiolabs in February 2022, the demand for prenatal paternity testing surged by 47.0% in 2021 versus pre-pandemic days. Therefore, such factors indicate increase in the demand of DTC (Direct to Consumer) DNA test kits, thereby propelling the market growth over the forecast period.

However, regulatory challenges pertaining to the use of DTC genetic tests are likely to impede the market growth over the forecast period.